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National Program in Japan
The national Japanese rare blood program was established 
in 1987 by the Japanese Red Cross (JRC). The JRC defined 
rare blood as one that occurs at a prevalence of 1:100 or 
less. The JRC classifies rare blood types into two categories 
according to their prevalence: those in category I are found 
in less than 1:10,000 individuals, and those in category II are 
found in between 1:100 and 1:10,000 individuals. Although 
the prevalence of the D– blood type is also low (1:200 in 
Japan), it is not considered rare, as we have no problem finding 
compatible blood because every donor is routinely typed for 
D. Phenotypes in category I are Mk/Mk, En(a−), Mi.V/Mi.V, 
Nsat/Nsat, S−/s−/U−, p, Pk, Rhnull, Rhmod, D−−, Dc−, RzRz, 
ryry, r ŕ ,́ Lu(a−b−), In(Lu), K0, Kp(a+b−), Kp(a−b−), k−, Kmod, 
K14−, K18−, KYOR−, Fy(a−b−), Jk(a−b−), Gy(a−), LW(a−b−), 
Oh (Bombay), para-Bombay, Kx− (McLeod), GE:−2,−3, IFC−, 
UMC−, Dr(a−), Ok(a−) , JMH−, I−, Lan−, Er(a−), and Emm−, 
and those in category II are s−, Fy(a−b+), Di(a+b−), Jr(a−), and 
Do(a+b−).
Donors are registered when their blood type is identified 
as rare and they are requested to donate their blood if needed. 
We usually keep blood in category I as frozen units. Blood in 
category II is usually supplied to hospitals as fresh units.
Number of Active Rare Donors
The JRC screens for rare cells on an automated analyzer 
(PK7300, Beckman Coulter K.K., Tokyo, Japan) using 
monoclonal antibodies, most of which were established by the 
JRC. The following monoclonal antibodies are routinely used 
for screening: anti-Rh17, anti-Jra, anti-K2 or anti-K14, anti-
EnaFR, anti-Ge, anti-Lan, anti-CD44, anti-Dib, anti-Oka, and 
anti-IFC.
Table 1 lists the number of active rare donors. Phenotypes 
that are the most difficult to find in Japan are MkMk, En(a−), 
U−, p, Pk, Rhnull, McLeod, Ge−, and Lan−. Table 2 shows the 65 
new rare donors added from 2012 to 2014.
Table 1. Number of active rare donors in Japan as of March 2015
Category I
Phenotype D+ D− Phenotype D+ D−
Oh (Bombay) 3 0 McLeod 18 0
MkMk 1 0 I− 20 0
En(a−) 2 0 Ge− 11 0
Mi.V/Mi.V 4 0 Lan− 19 0
Nsat/Nsat 2 0 Gy(a−) 6 0
S−s−U− 1 1 Ok(a−) 19 0
Pk 3 0 JMH− 12 0
Rhnull — 4 para-Bombay 78 0
Rhmod — 6 p 25 0
Kp(a−b−) 2 0 D−− 107 —
k− 9 0 In(Lu) 124 2
K:–14 2 0 K0 106 2
Fy(a−b−) 8 1 Jk(a−b−) 66 1
Dr(a−) 1 0
IFC− 1 0
Category I Category II
Rare phenotype D− Rare phenotype D+
Fy(a+b−) 491 Fy(a+b−) 3,416
Di(a+b−) 102 Di(a+b−) 2,785
Jr(a−) 44 Jr(a−) 2,323
s− 113 s− 357
Table 2. Rare donor entries in Japan from 2012 to 2014
Phenotype Number of donors
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Rare Units Shipped in 2012–2013
In Japan, one unit corresponds to 200 mL whole blood 
drawn from a donor. In 2012–2013, the JRC shipped 3897 
units of rare blood domestically and 21 units internationally 
(Table 3). The international shipments included 7 units of 
Lan− (red cell concentrates–leukocytes reduced [RCC-LR]), 
4 units of p (RCC-LR), and 2 units of D–– (RCC-LR) to 
Australia; 4 units of K0 (frozen thawed red cells–leukocytes 
reduced [FTRC-LR]) to the UK; and 4 units of Rhnull (FTRC-
LR) to Norway. 
Number of Requests not Filled
All cases for requested rare units of blood were filled in 
2012–2014.
Incompatible Transfusion Cases
Twelve cases (six cases of anti-Jra, one anti-Emm,1 one 
anti-Kpc, 1 anti-Ge, one anti-Gya, one anti-JMH, and one anti-
AnWj) of incompatible transfusions were reported between 
2012 and 2014. According to the reports, no prophylaxis was 
given in these 12 cases. Irregular antibodies could not be 
identified in the case of anti-Emm nor detected in the case of 
anti-Kpc in pre-transfusion tests. These antibodies led to acute 
hemolytic transfusion reactions; the other antibodies did not.
Incentives for Rare Donors
The JRC has no incentives for rare donors.
Rhnull Donors 
Rhnull donors are recognized as the most rare of the rare 
donors in the world. Currently, we have four group A, Rhnull 
donors; their molecular backgrounds have not been examined.
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Table 3. Rare units provided domestically and internationally 
through the Japanese Red Cross in 2012–2013
Domestic International
Phenotype Number of units Number of units Country
Jr(a–) 2113 0 NA
Fy(a–b+) 1255 0 NA
Di(a+b–) 330 0 NA
D−− 90 2 Australia
p 58 4 Australia
K0 12 4 UK
s– 14 0 NA
Lan– 3 7 Australia
I– 8 0 NA
Jk(a–b–) 4 0 NA
In(Lu) 4 0 NA
para-Bombay 4 0 NA
Rhnull 0 4 Norway
Fy(a–b–) 2 0 NA
Total 3897 21
NA = not applicable.
